Topic

Combination therapy treatment Steady

292 applications whose title mentions it. Its share of new filings over the last two years is 19% above the four years before.

Allowance rate

39%

−36 pts vs the USPTO 246 decided

Months to first action

17.6 mo

−1.0 vs the USPTO

Applications

292.0

in the record

Allowed

97.0

149 abandoned

Filings by year

How often the topic was filed

The most recent years are still filling in.

Where it is examined

Domains and art units

CPC subclasses

A61K244 apps

C07K22 apps

A61P17 apps

G01N5 apps

A61L1 apps

C12N1 apps

Art units

162829 apps

162924 apps

164422 apps

OPAP19 apps

164215 apps

162714 apps

Examiners

Who examines it, and how it fares with each

Docket Central19 apps

Phuong N Huynh16 apps

31%

Maury A Audet10 apps

50%

Karl J Puttlitz7 apps

60%

Patrick T Lewis6 apps

67%

Jon E Angell5 apps

75%

Andrew P Lee5 apps

50%

Prema Maria Mertz5 apps

25%

Bars show the share of decided applications that were allowed.

Unlock the examiners behind this topicIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who files it

Companies and institutions

ARENA PHARMACEUTICALS, INC.10 apps

50%

OPHTHOTECH CORPORATION8 apps

38%

Genentech, Inc.7 apps

43%

NOVARTIS AG7 apps

OncoMed Pharmaceuticals, Inc.7 apps

14%

Janssen Pharmaceutica NV5 apps

20%

Bars show the share of decided applications that were allowed.

Unlock the filers behind this topicIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who represents them

Law firms and agents

COOLEY LLP15 apps

42%

STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.14 apps

10%

FISH & RICHARDSON P.C. (ARENA PHARMACEUTICALS)10 apps

50%

C/O VP, IP, LEGAL8 apps

13%

FOLEY & LARDNER LLP7 apps

29%

Fish & Richardson PC (INCYTE)6 apps

100%

Bars show the share of decided applications that were allowed.

Unlock the firms behind this topicIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Applications

Recent applications on this topic

Application	Title	Filed	Status	Rejections	RCEs	To 1st action
19617685	COMBINATION THERAPY FOR THE TREATMENT OF OBESITY	2026-08-22	Pending	0	0	n/a
19598705	COMBINATION THERAPY FOR THE PREVENTION AND/OR THE TREATMENT OF A LIVER DISEASE	2026-06-18	Pending	0	0	n/a
19598960	COMBINATION THERAPY FOR TREATMENT OF METABOLIC DISEASE	2026-06-18	Pending	0	0	n/a
15127561	Method and apparatus for adaptive signal processing	2012-01-10	Allowed	1	0	12.0 mo
15143907	Composition and method for controlled release	2015-02-11	Abandoned	4	1	23.0 mo
15269036	Distributed ledger transaction verification	2018-03-12	Allowed	3	0	20.0 mo
15301191	Thermal management of battery assemblies	2021-04-13	Pending	2	1	17.0 mo
15709251	Machine learning model for anomaly detection	2012-05-14	Allowed	1	0	14.0 mo
15961360	Wireless power transfer coil arrangement	2015-06-15	Abandoned	4	1	25.0 mo
15900311	Catalyst for selective hydrogenation	2018-07-16	Allowed	3	0	22.0 mo

Unlock every application on this topic, with its timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in